Concentrix Corporation (CNXC) SEC Filings & Earnings Calls
EquiReason read 20 Concentrix Corporation SEC filings in the last 12 months. Latest: 10-Q on 2026-10-07 — Concentrix reported a GAAP net loss of $988M for Q3 FY2026, driven by a $1.05B goodwill impairment, with revenue declining 1.2% YoY; non-GAAP metrics showed slight improvement..
Source: SEC EDGAR filings · figures as of 2026-08-31 · read by EquiReason
- Market cap
- 2.0B
- P/E TTM
- —
- Dividend yield
- 4.6%
- 52-week
- —
- Next earnings
- 11 Jan, in 78 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
7 Oct 202610-QConcentrix reported a GAAP net loss of $988M for Q3 FY2026, driven by a $1.05B goodwill impairment, with revenue declining 1.2% YoY; non-GAAP metrics showed slight improvement.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2026 | $2.45B | -1% y/y |
| Net income (loss) · Q3-2026 | $-988M | -1221% y/y |
| Operating income (loss) · Q3-2026 | $-910M | -719% y/y |
| Adjusted EBITDA · Q3-2026 | $363M | +1% y/y |
| Free cash flow · 9M-2026 | $294M | +1% y/y |
| Diluted EPS (GAAP) · Q3-2026 | $-16.24 | -1312% y/y |
| Non-GAAP Diluted EPS · Q3-2026 | $2.92 | +5% y/y |
| Gross margin · Q3-2026 | 34.6% | |
| Operating cash flow · 9M-2026 | $443M | -4% y/y |
Risks flagged
Goodwill impairment risk
“As a result of the quantitative analysis performed, the carrying value of the Company’s reporting unit was determined to exceed its fair value, resulting in a non-cash goodwill impairment charge of $1,050,000.” · word for word
Client concentration and demand risk
“Revenue in our technology and consumer electronics vertical decreased by 10.0%, primarily due to decreases in revenue for certain larger clients in the vertical.” · word for word
Restructuring execution risk
“The Company recorded severance costs of $31,429 and $91,650 for the three and nine months ended August 31, 2026, respectively, primarily related to the Company’s cost reduction initiatives. These actions affected approximately 30,000 employees.” · word for word
Foreign exchange risk
“Foreign currency exchange rates had a negative impact of $16.2 million, or 0.7%, on revenue for the period.” · word for word
Leverage and debt service risk
“Total long-term debt, net $3,925,373 as of August 31, 2026.”
29 Sep 20268-K · 2.02Concentrix Q3 2026 revenue $2,453.7M (-1.2% YoY), non-GAAP op income $309M, adj EBITDA $363M, non-GAAP EPS $2.92. Includes $1.05B goodwill impairment. Guidance: Q4 rev $2.41-2.46B, FY rev $9.827-9.877B, adj FCF $630-650M.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2026 | $2.45B | -1% y/y |
| Non-GAAP operating income · Q3-2026 | $309M | +1% y/y |
| Adjusted EBITDA · Q3-2026 | $363M | +1% y/y |
| Non-GAAP diluted EPS · Q3-2026 | $2.92 | +5% y/y |
| Adjusted free cash flow · Q3-2026 | $218M | |
| Dividend per share · Q4-2026 | $0.37 |
Guidance
Q4 FY2026 revenue $2.41-2.46B; FY2026 revenue $9.827-9.877B; Q4 non-GAAP op income $310-320M; FY non-GAAP op income $1,206-1,216M; Q4 non-GAAP EPS $2.86-2.98; FY non-GAAP EPS $10.97-11.09; FY adj FCF $630-650M
Revenue guidance implies continued decline; margin expansion expected; management tone positive on AI-driven transformation
Risks flagged
Goodwill impairment of $1.05B signals overpayment for past acquisitions; stock price decline
“non-cash goodwill impairment charge of $1,050.0 million primarily resulting from the trading range for the Company’s stock price and market capitalization” · word for word
Revenue decline of 1.2% YoY; guidance implies further decline in Q4
“Revenue of $2,453.7 million, a decrease of (1.2)% year-on-year... Q4 revenue guidance $2.41-2.46B implies decline”
18 Sep 20268-K · 5.02Concentrix announces EVP Customer Success Cormac Twomey will step down effective Dec 31, 2026; transition support through Feb 2027.open
Risks flagged
Loss of a senior customer success executive may temporarily affect client relationships or retention.
“Departure of EVP Customer Success; transition support in place.”
24 Jul 20268-K · 5.02Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this reportopen
Risks flagged
No material financial or operational risk identified; severance plan update is standard governance practice.
“Plan aligns with market practice; no financial metrics or changes in executive roles disclosed.”
2 Jul 202610-QRevenue $2.46B (+2% y/y); Net income $55M (+31% y/y); Operating cash flow $175M (-27% y/y)open
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $2.46B | +2% y/y |
| Net income · Q2-2026 | $55M | +31% y/y |
| Operating cash flow · 6M-2026 | $175M | -27% y/y |
| Free cash flow · 6M-2026 | $73M | -45% y/y |
| Non-GAAP operating income · Q2-2026 | $292M | -4% y/y |
| Adjusted EBITDA · Q2-2026 | $347M | -3% y/y |
| Non-GAAP diluted EPS · Q2-2026 | $2.63 | -3% y/y |
Risks flagged
Margin compression from wage inflation and restructuring
“Gross margin % 33.4% vs 35.1%; operating margin 3.9% vs 6.1%.”
Client concentration and revenue volatility
“Revenue in technology and consumer electronics vertical decreased by 5.8%, primarily due to decreases in revenue for certain larger clients in the vertical.”
High leverage and debt service costs
“Interest expense and finance charges, net $68.1M (three months ended May 31, 2026).”
Foreign currency exposure
“Approximately 90% of consolidated revenue generated from non-U.S. operations.”
29 Jun 20268-K · 2.02Revenue $2.46B (+2% y/y); Operating income $95M (-36% y/y); Non-GAAP operating income $292M (-4% y/y); Guidance: Q3 revenue $2.465B-$2.490B; FY revenue $9.925B-$10.025B; FY adjusted free cash flow $630M-$650Mearningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $2.46B | +2% y/y |
| Operating income · Q2-2026 | $95M | -36% y/y |
| Non-GAAP operating income · Q2-2026 | $292M | -4% y/y |
| Net income · Q2-2026 | $55M | +31% y/y |
| Non-GAAP net income · Q2-2026 | $169M | -6% y/y |
| Adjusted EBITDA · Q2-2026 | $347M | -3% y/y |
| Cash flow from operations · Q2-2026 | $258M | |
| Adjusted free cash flow · Q2-2026 | $242M | |
| Diluted EPS · Q2-2026 | $0.86 | +37% y/y |
| Non-GAAP diluted EPS · Q2-2026 | $2.63 | -3% y/y |
Guidance
Q3 revenue $2.465B-$2.490B; FY revenue $9.925B-$10.025B; FY adjusted free cash flow $630M-$650M
Guidance reaffirmed with modest revenue growth expectations; margin pressure continues; strong cash flow generation.
Risks flagged
Margin compression from investments and mix shift.
“Non-GAAP operating margin down 70 bps to 11.9%”
Foreign exchange headwind on revenue.
“75-basis point negative impact of foreign exchange rates compared with prior year period” · word for word
1 May 2026SC 13D/AGBL group sold 6M shares of CNXC in a block trade, reducing stake to 4.55% and ceasing to be a 5% holder.open
Risks flagged
Major shareholder selling
“On April 29, 2026, Sapiens sold 6,000,000 shares of Common Stock for $22.25 per share, in a block trade pursuant to Rule 144.” · word for word
1 May 2026SC 13D/AGBL group sold 6M shares of CNXC in a block trade, reducing stake to 4.55% and ceasing to be a 5% holder.open
Risks flagged
Major shareholder selling
“On April 29, 2026, Sapiens sold 6,000,000 shares of Common Stock for $22.25 per share, in a block trade pursuant to Rule 144.” · word for word
3 Apr 202610-QQ1 2026 revenue grew 5.4% YoY but net income fell 69.3% and operating cash flow turned negative, with significant margin compression.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $2.50B | +5% y/y |
| Net Income · Q1-2026 | $22M | -69% y/y |
| Adjusted EBITDA · Q1-2026 | $348M | -7% y/y |
| Operating Cash Flow · Q1-2026 | $-83M |
Risks flagged
Margin compression from wage inflation and restructuring
“Gross margin % 34.0 % 36.1 %” · word for word
Negative operating cash flow
“Net cash used in operating activities was $83.2 million” · word for word
Tariff uncertainty impacting client demand
“The tariff environment remains dynamic, and we cannot predict with certainty the effect of future changes in global trade policy and tariffs on our clients’ operations and demand for our services in future periods.” · word for word
27 Mar 20268-K · 5.02, 5.07Additional shares authorized 3,700,000open
Figures in the filing · each found in the filing text
| Additional shares authorized · point_in_time | 3,700,000 |
Risks flagged
Potential dilution from increased share authorization.
“3,700,000 additional shares authorized for issuance under stock incentive plan.”
24 Mar 20268-K · 2.02Revenue $2.50B (+5% y/y); Operating income $119M (-30% y/y); Non-GAAP operating income $295M (-8% y/y); Guidance: Revenue guidance $10.035B-$10.180B; non-GAAP EPS $11.48-$12.07earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $2.50B | +5% y/y |
| Operating income · Q1-2026 | $119M | -30% y/y |
| Non-GAAP operating income · Q1-2026 | $295M | -8% y/y |
| Net income · Q1-2026 | $22M | -69% y/y |
| Non-GAAP net income · Q1-2026 | $168M | -11% y/y |
| Adjusted EBITDA · Q1-2026 | $348M | -7% y/y |
| Diluted EPS · Q1-2026 | $0.33 | -68% y/y |
| Non-GAAP diluted EPS · Q1-2026 | $2.61 | -7% y/y |
Guidance
Revenue guidance $10.035B-$10.180B; non-GAAP EPS $11.48-$12.07
Full-year guidance maintained; revenue growth expected 1.5%-3.0% constant currency; margin pressure from cost structure.
Risks flagged
Margin pressure from cost structure.
“Operating margin down 240 bps; non-GAAP operating margin down 180 bps.”
24 Feb 20268-K · 1.01, 2.03Concentrix issued $600M 6.500% Senior Notes due 2029, using proceeds to redeem $600M of 6.650% Notes due 2026, extending maturity and refinancing near-term debt.open
Figures in the filing · each found in the filing text
| aggregate principal amount of new notes · Q1-2026 | $600M | |
| interest rate on new notes · Q1-2026 | 6.5% | |
| interest rate on redeemed notes · Q1-2026 | 6.7% |
Risks flagged
New notes have a step-up coupon if credit ratings are downgraded, increasing interest cost risk.
“The interest rate payable on the Notes will be subject to adjustment from time to time if any of Moody’s, S&P or Fitch downgrades the debt rating applicable to the Notes.” · word for word
13 Feb 2026DEF 14AConcentrix filed its definitive proxy statement (DEF 14A) for the 2026 Annual Meeting, disclosing fiscal 2025 financial results, executive compensation details, and a proposal to increase the equity incentive plan share reserve by 3.7 milliopen
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $9.83B | +2% y/y |
| Non-GAAP operating income · FY2025 | $1.25B | -5% y/y |
| Non-GAAP operating margin · FY2025 | 12.8% | |
| Adjusted EBITDA · FY2025 | $1.47B | -6% y/y |
| Adjusted EBITDA margin · FY2025 | 15.0% | |
| Net income (loss) · FY2025 | $-1.28B | |
| Operating income (loss) · FY2025 | $-918M |
Risks flagged
Goodwill impairment risk
“Net loss of $(1,278.9) for fiscal year 2025 reflects a non-cash goodwill impairment charge of $1,523.3 million in the fourth quarter of 2025 primarily resulting from the trading range for our stock price and market capitalization.” · word for word
Margin compression
“Non-GAAP operating margin (1) 12.8 % 13.7 % (90) bps ... Adjusted EBITDA margin (1) 15.0 % 16.2 % (120) bps” · word for word
Underperformance of long-term incentive goals
“For the three-year performance-period ended November 30, 2025, the NEOs earned 11.67% of the PRSUs granted in January 2023” · word for word
Dilution from equity compensation
“At January 31, 2026, there were 769,067 shares remaining available for issuance under the 2020 Plan, representing 1.26% of our outstanding Common Stock as of that date. ... the 2020 Plan Amendment will provide us with an increased share reserve that will allow us to make equity awards ... for approximately two annual equity grant cycles.” · word for word
13 Feb 20268-K · 8.01Principal amount of senior notes issued $600M; principal amount of notes redeemed $600Mopen
Figures in the filing · each found in the filing text
| principal amount of senior notes issued · Q1-2026 | $600M | |
| principal amount of notes redeemed · Q1-2026 | $600M |
Risks flagged
Refinancing risk; new notes have higher coupon (6.500% vs 6.650% but longer maturity).
“Issuance of $600M 6.500% notes due 2029; redemption of 6.650% notes due 2026.”
28 Jan 202610-KRevenue $9.83B (+2% y/y); Net income (loss) $-1.28B; Gross margin % 35open
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $9.83B | +2% y/y |
| Net income (loss) · FY2025 | $-1.28B | |
| Gross margin % · FY2025 | 35.0% | |
| Adjusted EBITDA · FY2025 | $1.47B | -6% y/y |
| Adjusted EBITDA margin · FY2025 | 15.0% | |
| Non-GAAP diluted EPS · FY2025 | $11.22 | -2% y/y |
| Goodwill · FY2025 | $3.67B |
Risks flagged
Goodwill impairment risk
“the carrying value of our reporting unit was determined to exceed the fair value, resulting in a non-cash goodwill impairment charge of $1,523.3 million for the fiscal year ended November 30, 2025” · word for word
High leverage
“As of November 30, 2025, we had approximately $4.65 billion of indebtedness prior to debt issuance costs” · word for word
Foreign exchange risk
“approximately 89% and 88%, respectively, of our consolidated revenue was generated from our non-U.S. operations” · word for word
13 Jan 20268-K · 2.02Revenue $9.83B (+2% y/y); Revenue $2.55B (+4% y/y); Non-GAAP operating income $323M (-7% y/y); Guidance: Q1 FY2026 revenue guidance $2.475B-$2.500Bearningsopen
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $9.83B | +2% y/y |
| Revenue · Q4-2025 | $2.55B | +4% y/y |
| Non-GAAP operating income · Q4-2025 | $323M | -7% y/y |
| Adjusted EBITDA · Q4-2025 | $379M | -6% y/y |
| Non-GAAP diluted EPS · Q4-2025 | $2.95 | -10% y/y |
| Cash flow from operations · FY2025 | $807M | |
| Adjusted free cash flow · FY2025 | $626M |
Guidance
Q1 FY2026 revenue guidance $2.475B-$2.500B
Revenue guidance exceeded in FY2025; FY2026 guidance indicates ongoing growth and adjusted free cash flow expansion, but margins under pressure.
Risks flagged
Goodwill impairment of $1.52 billion indicates potential overpayment for acquisitions or declining market valuation.
“Non-cash goodwill impairment charge of $1,523.3 million primarily resulting from the trading range for the Company’s stock price and market capitalization.” · word for word
Concentrix Corporation — questions
- What did Concentrix Corporation file recently?
- 20 SEC filings in the last 12 months. Latest: 10-Q on 2026-10-07 — Concentrix reported a GAAP net loss of $988M for Q3 FY2026, driven by a $1.05B goodwill impairment, with revenue declining 1.2% YoY; non-GAAP metrics showed slight improvement.
Every figure on this page comes from Concentrix Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.